You have no items in your shopping cart.
We are pleased to announce that Biorbyt has been acquired by AVS Bio, a portfolio company of Arlington Capital Partners. This partnership is a fantastic milestone for Biorbyt, allowing us to combine our expansive catalog and reach with AVS Bio's extensive footprint. Find out more.
23rd September 2026
.png)
To learn about Biorbyt's new partnership with Vazyme and how it you in your research goals, please click here.
23rd May 2024
Check out our high-quality Custom Services for antibody and ELISA development, peptide production, buffer formulation, and conjugated antibodies. Find out more.
9th June 2023
Biorbyt is proud to have been presented a Queen’s Award for Enterprise in International Trade during a visit from Mrs Julie Spence, OBE, QPM, Her Majesty’s Lord-Lieutenant of Cambridgeshire. Find out more.
15th December 2021
We are immensely proud recipients of the Queen's Award for Enterprise: International Trade. This is a tremendous accolade and testament to all the hard work our team has done over the last decade. What an incredible way to celebrate our 10th year anniversary!
29th April 2021
2021 is a very special year for Biorbyt as we celebrate our tenth year. As a company, we are proud to serve a satisfied customer base. As an employer, we are excited to create a global business that supports, challenges, and nurtures talent. As a small business, we are part of a network of companies that support each other.
10th January 2021
Biorbyt has recently donated 50 goggles and 50 coverall suits to Addenbrooke's Hospital.
14th July 2020
